BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10403352)

  • 1. Determinants of retinopathy progression in type 1 diabetes mellitus.
    Cohen RA; Hennekens CH; Christen WG; Krolewski A; Nathan DM; Peterson MJ; LaMotte F; Manson JE
    Am J Med; 1999 Jul; 107(1):45-51. PubMed ID: 10403352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial.
    Arch Ophthalmol; 1995 Jan; 113(1):36-51. PubMed ID: 7826293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors influencing the onset and progression of diabetic retinopathy in subjects with insulin-dependent diabetes mellitus.
    Marshall G; Garg SK; Jackson WE; Holmes DL; Chase HP
    Ophthalmology; 1993 Aug; 100(8):1133-9. PubMed ID: 8341492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial of sorbinil, an aldose reductase inhibitor, in diabetic retinopathy. Sorbinil Retinopathy Trial Research Group.
    Arch Ophthalmol; 1990 Sep; 108(9):1234-44. PubMed ID: 2119168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sorbinil retinopathy trial: neuropathy results. Sorbinil Retinopathy Trial Research Group.
    Neurology; 1993 Jun; 43(6):1141-9. PubMed ID: 8170559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for progression of distal symmetric polyneuropathy in type 1 diabetes mellitus. Sorbinil Retinopathy Trial Research Group.
    Christen WG; Manson JE; Bubes V; Glynn RJ
    Am J Epidemiol; 1999 Dec; 150(11):1142-51. PubMed ID: 10588075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods to quantify the relation between disease progression in paired eyes.
    Glynn RJ; Rosner B
    Am J Epidemiol; 2000 May; 151(10):965-74. PubMed ID: 10853635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial.
    Arch Ophthalmol; 1998 Jul; 116(7):874-86. PubMed ID: 9682700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total Serum Cholesterol Increases Risk for Development and Progression of Nonproliferative Retinopathy in Patients with Type 1 Diabetes Without Therapeutic Intervention: Prospective, Observational Study.
    Bulum T; Tomić M; Duvnjak L
    Arch Med Res; 2017 Jul; 48(5):467-471. PubMed ID: 29089151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interval between onset of mild nonproliferative and proliferative retinopathy in type I diabetes.
    Vitale S; Maguire MG; Murphy RP; Hiner C; Rourke L; Sackett C; Patz A
    Arch Ophthalmol; 1997 Feb; 115(2):194-8. PubMed ID: 9046254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes.
    Klein R; Klein BE; Moss SE; Cruickshanks KJ
    Ophthalmology; 1998 Oct; 105(10):1801-15. PubMed ID: 9787347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cohort study of the relationship of diabetic retinopathy to blood pressure.
    Klein BE; Klein R; Moss SE; Palta M
    Arch Ophthalmol; 1995 May; 113(5):601-6. PubMed ID: 7748130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The progression of retinopathy over 2 years: the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study.
    Lloyd CE; Klein R; Maser RE; Kuller LH; Becker DJ; Orchard TJ
    J Diabetes Complications; 1995; 9(3):140-8. PubMed ID: 7548977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of cigarette smoking with diabetic retinopathy.
    Moss SE; Klein R; Klein BE
    Diabetes Care; 1991 Feb; 14(2):119-26. PubMed ID: 2060413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69.
    Matthews DR; Stratton IM; Aldington SJ; Holman RR; Kohner EM;
    Arch Ophthalmol; 2004 Nov; 122(11):1631-40. PubMed ID: 15534123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldose reductase inhibition fails to prevent retinopathy in diabetic and galactosemic dogs.
    Engerman RL; Kern TS
    Diabetes; 1993 Jun; 42(6):820-5. PubMed ID: 8495805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic retinopathy during pregnancy.
    Axer-Siegel R; Hod M; Fink-Cohen S; Kramer M; Weinberger D; Schindel B; Yassur Y
    Ophthalmology; 1996 Nov; 103(11):1815-9. PubMed ID: 8942876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group.
    Ophthalmology; 1995 Apr; 102(4):647-61. PubMed ID: 7724182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cigarette smoking and ten-year progression of diabetic retinopathy.
    Moss SE; Klein R; Klein BE
    Ophthalmology; 1996 Sep; 103(9):1438-42. PubMed ID: 8841303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure and the progression of mild background diabetic retinopathy.
    Chahal P; Inglesby DV; Sleightholm M; Kohner EM
    Hypertension; 1985; 7(6 Pt 2):II79-83. PubMed ID: 4077241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.